REMODELing mechanistic trials for kidney disease: a multimodal, tissue-centered approach to understand the renal mechanism of action of semaglutide is a research paper published in Kidney International (2025). On theSindex it has a DataRank of 0.342. It has been cited 8 times, with 7 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0.0125
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 7 citers.
National Institutes of Health
Grant: UL1TR002319
National Institutes of Health
Grant: UM1AI109568
National Institutes of Health
Grant: OT2HL161847
National Institutes of Health
Grant: OT2OD032581
National Institutes of Health
Grant: U01DK100846
National Institutes of Health
Grant: U54DK083912
National Institutes of Health
Grant: U2CDK114886
National Institutes of Health
Grant: R01MD014712
Juvenile Diabetes Research Foundation Canada
Grant: 3-SRA-2022-1243-M-B
Juvenile Diabetes Research Foundation Canada
Grant: 3-SRA-2023-1373-M-B
Bayer
Novo Nordisk
FWCI
5.73
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords